BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yin X, Deng N, Ding XY, Chen JL, Sun W. CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma. World J Gastroenterol 2025; 31(7): 101672 [PMID: 39991685 DOI: 10.3748/wjg.v31.i7.101672]
URL: https://www.wjgnet.com/1007-9327/full/v31/i7/101672.htm
Number Citing Articles
1
Shou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, Hsin-Ju Tsai, Chia-Chang Chen, Chung-Hsin Chang, Teng-Yu Lee, Yen-Chun Peng. CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on ImmunotherapyCancers 2025; 17(18): 3058 doi: 10.3390/cancers17183058